Ulrich Blaschke joined BioNTech in December 2019 as VP of Technical Development. In this role, he is responsible for the implementation of an integrated CMC development strategy for the BioNTech portfolio, working closely with the technical functions and CMC regulatory affairs. Besides the technical aspects, he is specifically interested in the evolving global regulatory framework for this new class of therapeutic molecules.